Titan Pharmaceuticals (TTP) Announces Amendment to Partnership With Braeburn Pharmaceuticals
5/30/2013 11:10:30 AM
More...
|
Titan Pharmaceuticals (TTP) Schedules Conference Call to Review First Quarter 2013 Financial Results
5/9/2013 11:05:09 AM
More...
|
FDA Delays Approval of Titan Pharmaceuticals (TTP)'s Suboxone Implant
5/1/2013 8:33:36 AM
More...
|
Titan Pharmaceuticals (TTP)' Probuphine Program to be Presented at ASAM Medical-Scientific Conference and American Psychiatric Association Annual Meeting
4/22/2013 12:25:07 PM
More...
|
Titan Pharmaceuticals (TTP) Announces FDA Advisory Committee Recommends Approval of Probuphine for the Treatment of Adult Patients With Opioid Dependence
3/22/2013 8:56:08 AM
More...
|
FDA Reviewers Say Titan Pharmaceuticals (TTP) Drug Dose May be Insufficient
3/20/2013 7:53:09 AM
More...
|
Titan Pharmaceuticals (TTP) Announces Fourth Quarter and Year End 2012 Financial Results
3/15/2013 11:30:04 AM
More...
|
Titan Pharmaceuticals (TTP) Schedules Conference Call to Review Fourth Quarter and Full Year 2012 Financial Results
3/11/2013 9:55:46 AM
More...
|
Titan Pharmaceuticals (TTP) Announces Date of FDA Advisory Committee Review of Probuphine® for the Treatment of Opioid Dependence
2/27/2013 10:34:20 AM
More...
|
Titan Pharmaceuticals (TTP) Release: Probuphine® Receives FDA Priority Review Designation for Adult Patients With Opioid Dependence
1/2/2013 8:26:55 AM
More...
|
|